Zucara Therapeutics

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

DiogenX

This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.

Sequel Med Tech

This medical device company develops automated insulin delivery systems for patients with type 1 diabetes to improve medication dosing and disease management.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.

Encellin

The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.

Luna Health

This company develops automated insulin delivery patch pumps and dosing algorithms to manage glucose levels for people with insulin-dependent diabetes.

Calibra Medical

This company develops wearable, mechanical insulin delivery patches for individuals with type one and type two diabetes to simplify mealtime therapy.

Viacyte

This regenerative medicine company develops stem cell-derived islet replacement therapies for patients living with type 1 diabetes.